Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204462
Max Phase: Preclinical
Molecular Formula: C33H42N6O6S
Molecular Weight: 650.80
Associated Items:
ID: ALA5204462
Max Phase: Preclinical
Molecular Formula: C33H42N6O6S
Molecular Weight: 650.80
Associated Items:
Canonical SMILES: COc1ccc(-c2cccc(S(=O)(=O)N[C@@H](Cc3cccc(C(=N)N)c3)C(=O)N3CCC(NC(=O)NC(C)C)CC3)c2)c(OC)c1
Standard InChI: InChI=1S/C33H42N6O6S/c1-21(2)36-33(41)37-25-13-15-39(16-14-25)32(40)29(18-22-7-5-9-24(17-22)31(34)35)38-46(42,43)27-10-6-8-23(19-27)28-12-11-26(44-3)20-30(28)45-4/h5-12,17,19-21,25,29,38H,13-16,18H2,1-4H3,(H3,34,35)(H2,36,37,41)/t29-/m0/s1
Standard InChI Key: HFNBDSZCUXAFFG-LJAQVGFWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 650.80 | Molecular Weight (Monoisotopic): 650.2887 | AlogP: 3.24 | #Rotatable Bonds: 12 |
Polar Surface Area: 175.94 | Molecular Species: BASE | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.02 | CX Basic pKa: 11.47 | CX LogP: 1.72 | CX LogD: -0.19 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.15 | Np Likeness Score: -1.11 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):